Press Releases Details

Home  >  Investors & News  >  Press Releases  >  Press Releases Details
View all news

Momenta Pharmaceuticals to Webcast Presentation at the 35th Annual J. P. Morgan Healthcare Conference


CAMBRIDGE, Mass., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler, President and CEO, will present at the 35th Annual J. P. Morgan Healthcare Conference. The presentation is scheduled for Tuesday, January 10th at 3:00 p.m. PT (6:00 p.m. ET).

Following the presentation, management will participate in a question and answer session at 3:30 p.m. PT (6:30 p.m. ET).

The webcast of the presentation and Q&A session will be available live on the "Investors" section of the company's website located at  A replay of the presentation will be posted on the Momenta website approximately one hour after the event.

About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.


Sarah CarmodyMomenta Pharmaceuticals


Primary Logo

Momenta Pharmaceuticals, Inc.

News Provided by Acquire Media

Multimedia Files:

View all news